Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.  Llorens-Revull M, Costafreda MI, Rico A, Guerrero-Murillo M, Soria ME, Píriz-Ruzo S, et al. (2021)  PLoS ONE 16(7...

Manual: Increasing access to hepatitis C testing and care for people who inject drugs This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barrier...

„Hepatitis kann nicht warten!“ – die Deutsche Leberstiftung fordert anlässlich des Welt-Hepatitis-Tages mehr Engagement Am 28. Juli 2021 findet der Welt-Hepatitis-Tag statt. Das diesjährige Motto „Hepatitis kann nicht warten!“ ist eine eindringli...

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study.  Goutzamanis, S., Horyniak, D., Doyle, J.S. et al. Harm Reduct J 18, 73 (2021). doi.org/10.1186/s12954-021-00516-1 ...

A Feasibility Study to Increase Chronic Hepatitis CVirus RNA Testing and Linkage to Care among Clients Attending Homeless Services in Amsterdam,The Netherlands. Generaal, E.; Logtenbergvan der Grient, H.; Schatz, E.; vanSanten, D.K.; Boyd, A.; Wo...

Therapy of chronic hepatitis C in people who inject drugs: focus on adherence. Frankova, S., Jandova, Z., Jinochova, G. et al.  Harm Reduct J 18, 69 (2021). doi.org/10.1186/s12954-021-00519-y https://harmreductionjournal.biomedcentral.com/...